-
Scandic Trust Group strengthens sales network with First Idea Consultant
-
Tight UK security ahead of match against Israeli club
-
Ethiopia's Afar region says attacked by Tigray forces
-
Nancy Pelosi, Democratic giant, Trump foe, first woman House speaker, to retire
-
Israel strikes Hezbollah targets in Lebanon
-
Burger strikes as South Africa restrict Pakistan to 269-9 in second ODI
-
Stocks slip as investors weigh earnings, tariffs
-
Police say 19 held after raid at Swedish start-up Stegra to be deported
-
Kante returns as France seek to clinch World Cup berth
-
Marcus Smith starts at full-back as England ring changes for Fiji
-
Kolisi 100th Test 'no distraction' for Erasmus' South Africa
-
Teetering Belgian government given more time to agree budget
-
Merz backs EU plan to protect steel sector from Chinese imports
-
New Zealand make Scotland changes after Barrett brothers' injuries
-
'Roy of the Rovers story' -- Farrell handed Ireland debut for Japan Test
-
Stones backs Man City team-mate Foden to pose England dilemma for Tuchel
-
Djokovic to face Alcaraz in ATP Finals groups
-
Facing climate 'overshoot', world heads into risky territory
-
Springbok skipper Kolisi to play 100th Test against France
-
Typhoon Kalmaegi hits Vietnam after killing 140 in Philippines
-
Bank of England leaves rate unchanged before UK budget
-
Germany recall Sane, hand El Mala debut for World Cup qualifers
-
India thump Australia to take 2-1 lead in T20 series
-
Cameroon's Biya, world's oldest president, sworn in for 8th term
-
Flick holding firm on Barca high line despite defensive woes
-
Battered US businesses eye improved China trade at Shanghai expo
-
France opt for Le Garrec as Dupont replacement for 'best team ever' South Africa
-
Drugmaker AstraZeneca profit jumps as US business grows
-
'Vibe coding' named word of the year by Collins dictionary
-
Vietnam evacuates thousands from coast ahead of Typhoon Kalmaegi
-
European stocks fall after gains in Asia, US
-
MotoGP legend Agostini admires Marc Marquez's 'desire to win'
-
Nepal searches for avalanche victims
-
Hezbollah rejects any negotiations between Lebanon and Israel
-
Chapman blitz leads Black Caps to tight T20 victory over West Indies
-
France urges EU to sanction Shein platform
-
France opt for Le Garrec as Dupont replacement for South Africa Test
-
Turmoil in tiaras at Miss Universe pageant in Thailand
-
Probe into Thales defence group looking at Indonesian contract
-
US to cancel flights as longest govt shutdown drags on
-
Home in Nigeria, ex-refugees find themselves in a war zone
-
Doncic's Lakers hold off Wembanyama's Spurs, Blazers silence Thunder
-
For Turkey's LGBTQ community, draft law sparks existential alarm
-
Musk's $1 trillion pay package to face Tesla shareholder vote
-
Tonga rugby league star out of intensive care after seizure
-
Argentine ex-president Kirchner goes on trial in new corruption case
-
Dams, housing, pensions: Franco disinformation flourishes online
-
Endo returns as Japan look to build on Brazil win
-
Franco captivates young Spaniards 50 years after death
-
German steel industry girds for uncertain future
AI tool uses selfies to predict biological age and cancer survival
Doctors often start exams with the so-called "eyeball test" -- a snap judgment about whether the patient appears older or younger than their age, which can influence key medical decisions.
That intuitive assessment may soon get an AI upgrade.
FaceAge, a deep learning algorithm described Thursday in The Lancet Digital Health, converts a simple headshot into a number that more accurately reflects a person's biological age rather than the birthday on their chart.
Trained on tens of thousands of photographs, it pegged cancer patients on average as biologically five years older than healthy peers. The study's authors say it could help doctors decide who can safely tolerate punishing treatments, and who might fare better with a gentler approach.
"We hypothesize that FaceAge could be used as a biomarker in cancer care to quantify a patient's biological age and help a doctor make these tough decisions," said co-senior author Raymond Mak, an oncologist at Mass Brigham Health, a Harvard-affiliated health system in Boston.
Consider two hypothetical patients: a spry 75‑year‑old whose biological age clocks in at 65, and a frail 60‑year‑old whose biology reads 70. Aggressive radiation might be appropriate for the former but risky for the latter.
The same logic could help guide decisions about heart surgery, hip replacements or end-of-life care.
- Sharper lens on frailty -
Growing evidence shows humans age at different rates, shaped by genes, stress, exercise, and habits like smoking or drinking. While pricey genetic tests can reveal how DNA wears over time, FaceAge promises insight using only a selfie.
The model was trained on 58,851 portraits of presumed-healthy adults over 60, culled from public datasets.
It was then tested on 6,196 cancer patients treated in the United States and the Netherlands, using photos snapped just before radiotherapy. Patients with malignancies looked on average 4.79 years older biologically than their chronological age.
Among cancer patients, a higher FaceAge score strongly predicted worse survival -- even after accounting for actual age, sex, and tumor type -- and the hazard rose steeply for anyone whose biological reading tipped past 85.
Intriguingly, FaceAge appears to weigh the signs of aging differently than humans do. For example, being gray-haired or balding matters less than subtle changes in facial muscle tone.
FaceAge boosted doctors' accuracy, too. Eight physicians were asked to examine headshots of terminal cancer patients and guess who would die within six months. Their success rate barely beat chance; with FaceAge data in hand, predictions improved sharply.
The model even affirmed a favorite internet meme, estimating actor Paul Rudd's biological age as 43 in a photo taken when he was 50.
- Bias and ethics guardrails -
AI tools have faced scrutiny for under‑serving non-white people. Mak said preliminary checks revealed no significant racial bias in FaceAge's predictions, but the group is training a second‑generation model on 20,000 patients.
They're also probing how factors like makeup, cosmetic surgery or room lighting variations could fool the system.
Ethics debates loom large. An AI that can read biological age from a selfie could prove a boon for clinicians, but also tempting for life insurers or employers seeking to gauge risk.
"It is for sure something that needs attention, to assure that these technologies are used only in the benefit for the patient," said Hugo Aerts, the study's co-lead who directs MGB's AI in medicine program.
Another dilemma: What happens when the mirror talks back? Learning that your body is biologically older than you thought may spur healthy changes -- or sow anxiety.
The researchers are planning to open a public-facing FaceAge portal where people can upload their own pictures to enroll in a research study to further validate the algorithm. Commercial versions aimed at clinicians may follow, but only after more validation.
F.Pedersen--AMWN